Related Experiment Video
Updated: Jul 19, 2026
08:32
Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Gastrointestinal infections in children.
1Division of Pediatric Gastroenterology and Nutrition, Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.
Current Opinion in Gastroenterology
|October 7, 2006
Summary
New diagnostic tests and treatments, including probiotics and novel vaccines, are improving the management of childhood gastroenteritis. Faster pathogen identification and potential edible vaccines represent significant advancements in pediatric infectious disease.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Vaccinology
Background:
- Emerging and re-emerging pathogens are increasingly recognized as causes of pediatric gastroenteritis.
- Standard diagnostic and treatment protocols for pathogens like Clostridium difficile require re-evaluation.
- Rapid advancements in diagnostic technologies and therapeutic strategies are transforming the field.
Purpose of the Study:
- To review recent advancements in the diagnosis and treatment of pediatric gastroenteritis.
- To highlight novel diagnostic tools and therapeutic interventions.
- To discuss the future of vaccine development for gastroenteritis.
Main Methods:
- Literature review of recent studies on pediatric gastroenteritis.
- Analysis of emerging diagnostic technologies for pathogen identification.
- Evaluation of novel treatment strategies, including probiotics and vaccine development.
Main Results:
- New diagnostic tests enable faster pathogen identification, potentially allowing same-day results.
- Probiotic therapy is emerging as a viable treatment option for gastroenteritis.
- Development of new vaccines against viral and bacterial gastroenteritis is ongoing, with edible vaccines showing promise.
Conclusions:
- Rapid diagnostics and novel therapeutics are enhancing the management of childhood gastroenteritis.
- Continued research into vaccines, including innovative approaches like edible vaccines, holds significant potential for prevention.
- The landscape of pediatric gastroenteritis management is rapidly evolving with new scientific breakthroughs.
Related Concept Videos
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:12Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:27Microbiota of the Stomach and Small Intestine
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
01:30Other Disorders of Digestive System
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...